Top Story

Early DAPT reduces recurrent neurological events before expedited CEA

October 9, 2015

Among patients who received expedited carotid endarterectomy, early administration of dual antiplatelet therapy decreased recurrent neurological events and spontaneous embolization before the procedure, without significantly increasing major perioperative bleeding complications.

Researchers performed a prospective audit of 100 consecutive, recently symptomatic patients who received DAPT. Endpoint measures included prevalence of recurrent events between transfer from the transient ischemic attack clinic to carotid endarterectomy (CEA); rates of spontaneous embolization before undergoing CEA; and prevalence of hemorrhagic complications.

In the Journals

Endothelial function may improve in patients with inflammatory joint diseases treated with Crestor

October 9, 2015
Patients with inflammatory joint diseases, including rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, who had carotid plaque verified by ultrasound…
Barry A. Borlaug, MD In the Journals

Sodium nitrite infusion improves exercise hemodynamics, cardiac reserve in patients with HFpEF

October 9, 2015
Compared with placebo, sodium nitrite infusion improved exercise hemodynamics and enhanced cardiac reserve for patients with HF with preserved ejection fraction…
Deepak L. Bhatt, MD, MPH In the Journals

Future role of clinical registries predicted to influence care

October 9, 2015
Clinical registries “will be able to influence care profoundly” in the future and will complement, rather than be made obsolete by, electronic health records…

CMS, ONC issue new rules to make EHR better accessed, more useful

October 9, 2015
HHS has issued new rules to the Electronic Heath Record Incentive Program and the Health IT Certification Program that will make EHR information more available to…
More News Headlines »
J832 Activity Image 2

Antiplatelet Agents for Secondary Prevention of Thrombotic Cardiovascular Events in Patients with History of Myocardial Infarction

This activity is supported by an educational grant from Merck & Co., Inc.

In this CME activity, Dr. Deepak Bhatt discusses the use of antiplatelet for secondary prevention of thrombotic…
More »
Meeting News Coverage Video
VIDEO: HFSA symposium offers insight into potential new treatment opportunity for HF

VIDEO: HFSA symposium offers insight into potential new treatment opportunity for HF

October 3, 2015
NATIONAL HARBOR, Md. — In this video, Clyde W. Yancy, MD, MSc, chief of cardiology at Northwest University…
More »
Cardiology Case Consults

The Patient With Severe Hypertriglyceridemia

No commercial support for this activity.

Elevated serum triglycerides are a highly prevalent yet modifiable risk factor for atherosclerotic disease and its…
More »